[{"Assets_0_Q1_USD":163203007.0,"CommonStockSharesOutstanding_0_Q1_shares":50429020.0,"NetIncomeLoss_1_Q1_USD":-21736304.0,"StockholdersEquity_0_Q1_USD":129042105.0,"Ticker":"APLS","CIK":"1492422","name":"APELLIS PHARMACEUTICALS, INC.","OfficialName":"Apellis Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"5553923312.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180430"}]